In Good Company with Nicolai Tangen GSK CEO: Drug Discovery, AI in Pharma, and Changing Company Culture
49 snips
Apr 2, 2025 
In this engaging discussion, Emma Walmsley, CEO of GSK and a key player in pharmaceuticals, shares insights on drug discovery and the integration of AI in speeding up medical advancements. She highlights GSK's breakthroughs in cancer treatments and respiratory medicine, while tackling the challenges of drug pricing and access. Emma also emphasizes the need for culture change within companies to foster innovation and accountability, and the significance of curiosity in leadership. Tune in for a captivating look at the future of healthcare!
AI Snips
Chapters
Books
Transcript
Episode notes
Healthcare Data Explosion
- Healthcare data is exploding, offering massive potential for improvement.
- AI can revolutionize drug discovery and development by leveraging this data.
AI in Clinical Trials
- AI is being used to improve clinical trial design and predict outcomes.
- It's also used to track infectious disease patterns, accelerating research.
Embrace AI for Innovation
- Pharmaceutical companies must embrace AI and technology to address unmet medical needs.
- This will improve drug development and benefit patients globally.
